Institute for Translational Medicine and Therapeutics and Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Mol Immunol. 2010 Aug;47(13):2176-86. doi: 10.1016/j.molimm.2010.05.008. Epub 2010 Jun 18.
Complement is a part of the innate immune system that contributes to first-line host defense. It is also implicated in a number of human inflammatory conditions and has attracted interest as a potential therapeutic target. Understanding the basic biology of complement and its mechanism(s) of action is imperative for developing complement-based treatments for infectious and autoimmune diseases. One of the exciting new developments in this regard is the revelation that complement plays an important role in T cell immunity. In this review, we highlight recent published studies implicating complement in models of CD4+ and CD8+ T cell immune responses, and discuss its potential mechanism(s) action in these processes. We also comment on issues that may impact data interpretation and draw attention to their consideration in future studies.
补体是先天免疫系统的一部分,有助于宿主的第一道防线。它还与许多人类炎症性疾病有关,并引起了作为潜在治疗靶点的兴趣。了解补体的基本生物学及其作用机制对于开发针对感染性和自身免疫性疾病的基于补体的治疗方法至关重要。在这方面令人兴奋的新进展之一是揭示补体在 CD4+和 CD8+T 细胞免疫反应模型中发挥重要作用。在这篇综述中,我们强调了最近发表的研究,这些研究表明补体参与了 CD4+和 CD8+T 细胞免疫反应的模型,并讨论了其在这些过程中的潜在作用机制。我们还评论了可能影响数据解释的问题,并提请注意在未来的研究中考虑这些问题。